advertisement

---

Traverso CE 1

Showing records 1 to 1 | Display all abstracts from Traverso CE

60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Pfeiffer N; Traverso CE; Lorenz K; Saarela V; Liinamaa J; Uusitalo H; Astakhov Y; Boiko E; Ropo A;
Advances in Therapy 2014; 31: 1228-1246

---